Lymph-Node-Targeted Cholesterolized TLR7 Agonist Liposomes Provoke a Safe and Durable Antitumor Response
Source abstract
Abstract
T cell responses. Furthermore, 1V209-Cho-Lip induced tumor-specific memory immunity to inhibit cancer recurrence and metastasis. These results indicate that cholesterol conjugation with 1V209 is an effective approach to target lymph nodes and to reduce the adverse effects. This work provides a rational basis for the distribution optimization of TLR agonists for potential clinical use.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Immunotherapy and Immune Responses · Immune Response and Inflammation · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, No. 17, Block 3, Southern Renmin Road, Chengdu, Sichuan 610041, PR China
Funding
the National Natural Science Foundation Regional Innovation and Development · the Development Program of China · the Excellent Youth Foundation of Sichuan Scientific Committee Grant in China
References (40)
Show source-provided references
1. 10.1016/j.biopha.2020.10982110.1016/j.biopha.2020.109821 ↗
2. 10.1038/ni.239210.1038/ni.2392 ↗
3. 10.1002/jcp.2778210.1002/jcp.27782 ↗
4. 10.1016/j.it.2017.04.00210.1016/j.it.2017.04.002 ↗
5. 10.1146/annurev.immunol.22.012703.10453810.1146/annurev.immunol.22.012703.104538 ↗
6. 10.1016/j.biomaterials.2020.12020810.1016/j.biomaterials.2020.120208 ↗
7. 10.1038/nrc325810.1038/nrc3258 ↗
8. 10.1126/science.123222710.1126/science.1232227 ↗
9. 10.1093/annonc/mdx68310.1093/annonc/mdx683 ↗
10. 10.4049/jimmunol.160114510.4049/jimmunol.1601145 ↗
11. 10.1080/2162402X.2018.152625010.1080/2162402X.2018.1526250 ↗
12. 10.1172/JCI7991510.1172/JCI79915 ↗
13. 10.1586/ecp.11.510.1586/ecp.11.5 ↗
14. 10.1177/009127000730376610.1177/0091270007303766 ↗
15. 10.1182/blood-2008-04-15171210.1182/blood-2008-04-151712 ↗
16. 10.1182/blood-2012-05-43239310.1182/blood-2012-05-432393 ↗
17. 10.1073/pnas.063169610010.1073/pnas.0631696100 ↗
18. 10.1074/jbc.M31161820010.1074/jbc.M311618200 ↗
19. 10.1038/sj.onc.121091310.1038/sj.onc.1210913 ↗
20. 10.1073/pnas.160081611310.1073/pnas.1600816113 ↗
21. 10.1073/pnas.110520010810.1073/pnas.1105200108 ↗
22. 10.1038/nature1297810.1038/nature12978 ↗
23. 10.1038/nbt133210.1038/nbt1332 ↗
24. 10.1073/pnas.110426410810.1073/pnas.1104264108 ↗
25. 10.1038/nmat296010.1038/nmat2960 ↗
26. 10.1007/s11427-018-9470-910.1007/s11427-018-9470-9 ↗
27. 10.3389/fimmu.2019.0086310.3389/fimmu.2019.00863 ↗
28. 10.1126/science.aal362210.1126/science.aal3622 ↗
29. 10.1126/science.aal366210.1126/science.aal3662 ↗
30. 10.4161/cc.5.8.264610.4161/cc.5.8.2646 ↗
31. 10.1126/science.107142010.1126/science.1071420 ↗
32. 10.1038/nbt133910.1038/nbt1339 ↗
33. 10.1016/j.cmet.2013.04.00210.1016/j.cmet.2013.04.002 ↗
34. 10.1021/ja046663o10.1021/ja046663o ↗
35. 10.1002/anie.20150878310.1002/anie.201508783 ↗
36. 10.1002/anie.20110126610.1002/anie.201101266 ↗
37. 10.1038/ni75810.1038/ni758 ↗
38. 10.1002/adfm.20170724910.1002/adfm.201707249 ↗
39. 10.1358/dot.1999.35.7.54826310.1358/dot.1999.35.7.548263 ↗
40. 10.3967/bes2014.01210.3967/bes2014.012 ↗